1102 related articles for article (PubMed ID: 18544264)
41. Neoplastic mesorectal microfoci (MMF) following neoadjuvant chemoradiotherapy: clinical and prognostic implications.
Ratto C; Ricci R; Valentini V; Castri F; Parello A; Gambacorta MA; Cellini N; Vecchio FM; Doglietto GB
Ann Surg Oncol; 2006 Nov; 13(11):1393-402. PubMed ID: 17013687
[TBL] [Abstract][Full Text] [Related]
42. Management of resectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria.
Rich TA; Ota D; Rosenthal SA; Minsky BD; Bader JL; Coia LR; Janjan NA; John MJ; Merrick GS; Raben D; Tepper JE; Saltz L; Leibel S
Radiology; 2000 Jun; 215 Suppl():1473-80. PubMed ID: 11037560
[No Abstract] [Full Text] [Related]
43. T-level downstaging and complete pathologic response after preoperative long-term radiochemotherapy for locally advanced rectal cancer.
Jonas J; Moroni E; Cavallaro A; Colasanti M; Sautter-Bihl ML; Frenzel H; Lohe B; Bähr R
G Chir; 2007 Mar; 28(3):65-71. PubMed ID: 17419902
[TBL] [Abstract][Full Text] [Related]
44. [Efficacy of local resection on lower rectal cancer of early stage: efficacy of report of 23 cases].
Hong J; Tang YQ
Ai Zheng; 2005 Jan; 24(1):79-81. PubMed ID: 15642206
[TBL] [Abstract][Full Text] [Related]
45. Analysis of outcome using a levator sparing technique of abdominoperineal excision of rectum and anus. Cylindrical ELAPE is not necessary in all patients.
Ramsay G; Parnaby C; Mackay C; Hanlon P; Ong S; Loudon M
Eur J Surg Oncol; 2013 Nov; 39(11):1219-24. PubMed ID: 23973512
[TBL] [Abstract][Full Text] [Related]
46. [Neoadjuvant chemoradiation therapy for locally advanced rectal cancer].
Sato T; Ozawa H; Kisyu K; Kumamoto H; Nakamura T; Onozato W; Yamanashi T; Kokuba Y; Ihara A; Watanabe M
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1553-6. PubMed ID: 17940371
[TBL] [Abstract][Full Text] [Related]
47. [Excision of low rectal carcinomas with sphincter preservation. Multimodal strategy using neoadjuvant radiotherapy and "delayed" coloanal anastomosis without defunctioning stoma].
Baulieux J; Mabrut JY; Adham M; de La Roche E; Olagne E; Ducerf C; Romestaing P; Gerard JP
Bull Acad Natl Med; 2004; 188(9):1509-24; discussion 1524-7. PubMed ID: 15997621
[TBL] [Abstract][Full Text] [Related]
48. Local excision for early rectal cancer in the era of neoadjuvant strategies.
Tepetes K; Spyridakis ME
Hepatogastroenterology; 2007 Sep; 54(78):1689-93. PubMed ID: 18019696
[TBL] [Abstract][Full Text] [Related]
49. [Value of local surgical therapy for rectal cancer. A literature analysis].
Borschitz T; Junginger T
Zentralbl Chir; 2003 Dec; 128(12):1066-74. PubMed ID: 14750068
[TBL] [Abstract][Full Text] [Related]
50. [Rectal cancer: treatment and results].
Luna Pérez P
Rev Invest Clin; 2001; 53(1):65-76. PubMed ID: 11332053
[No Abstract] [Full Text] [Related]
51. [Importance of neoadjuvant chemotherapy in gastrointestinal tumors. A new standard?].
Moosmann N; Boeck S; Heinemann V
Med Klin (Munich); 2007 Jul; 102(7):551-62; quiz 563-4. PubMed ID: 17634873
[No Abstract] [Full Text] [Related]
52. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E
Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401
[TBL] [Abstract][Full Text] [Related]
53. Complete clinical and pathological response to preoperative short course radiotherapy in T 2 rectal cancer.
Selvasekar CR; Obeidat S; Simcock P; Khan AU
Indian J Cancer; 2009; 46(4):350-1. PubMed ID: 19749473
[No Abstract] [Full Text] [Related]
54. Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy.
Grillo-Ruggieri F; Mantello G; Berardi R; Cardinali M; Fenu F; Iovini G; Montisci M; Fabbietti L; Marmorale C; Guerrieri M; Saba V; Bearzi I; Mattioli R; Bonsignori M; Cascinu S
Dis Colon Rectum; 2007 Oct; 50(10):1594-603. PubMed ID: 17846841
[TBL] [Abstract][Full Text] [Related]
55. The multidisciplinary management of rectal cancer.
Meredith KL; Hoffe SE; Shibata D
Surg Clin North Am; 2009 Feb; 89(1):177-215, ix-x. PubMed ID: 19186236
[TBL] [Abstract][Full Text] [Related]
56. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.
Perez RO; São Julião GP; Habr-Gama A; Kiss D; Proscurshim I; Campos FG; Gama-Rodrigues JJ; Cecconello I
Dis Colon Rectum; 2009 Jun; 52(6):1137-43. PubMed ID: 19581858
[TBL] [Abstract][Full Text] [Related]
57. [Adjuvant therapy of rectal cancer].
Bouaouina N; Boussen H
Tunis Med; 2003 Feb; 81(2):73-9. PubMed ID: 12708171
[TBL] [Abstract][Full Text] [Related]
58. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging.
Koh DM; Chau I; Tait D; Wotherspoon A; Cunningham D; Brown G
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):456-61. PubMed ID: 18164860
[TBL] [Abstract][Full Text] [Related]
59. [Cyto-reduction of rectal cancer after preoperative chemoradiotherapy].
Sánchez Maldonado W; Rodríguez Coria D; Luna Pérez P
Rev Gastroenterol Mex; 1995; 60(3):158. PubMed ID: 7481450
[No Abstract] [Full Text] [Related]
60. Patient-reported outcomes after neoadjuvant chemoradiotherapy for rectal cancer: a multicenter prospective observational study.
Pucciarelli S; Del Bianco P; Efficace F; Serpentini S; Capirci C; De Paoli A; Amato A; Cuicchi D; Nitti D
Ann Surg; 2011 Jan; 253(1):71-7. PubMed ID: 21135694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
